Evaluating Retinopathy of Prematurity in Preterm Infants in Turkey
Evaluation of the Frequency of Retinopathy of Prematurity, Influencing Risk Factors, and Treatment Outcomes in Premature Infants With a Birth Weight >1500 Grams or Gestational Age ≥33 Weeks in Turkey.
This study is trying to find out how common retinopathy of prematurity is in preterm infants in Turkey and what treatments are being used for it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 28 Days and up |
| Sex | All |
| Sponsor | Baskent University Ankara Hospital Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06265363 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on preterm infants in Turkey who are screened for retinopathy of prematurity (ROP) between August 1, 2023, and August 1, 2024. It includes infants with a birth weight greater than 1500 grams or a gestational age of 33 weeks or more. The study aims to determine the incidence of ROP, severe ROP, and the various treatment modalities used, while also evaluating risk factors associated with ROP development. Data will be collected through an electronic questionnaire filled out by certified neonatologists across 94 neonatal intensive care units (NICUs).
Who should consider this trial
Good fit: Ideal candidates for this study are preterm infants with a birth weight greater than 1500 grams or a gestational age of 33 weeks or more who are being screened for ROP.
Not a fit: Patients who may not benefit from this study include neonates who die before their first ROP examination.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of ROP in preterm infants, potentially leading to better outcomes.
How similar studies have performed: Other studies have shown success in evaluating ROP in similar populations, indicating that this approach is supported by existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants with BW \>1500 g or ≥33 weeks' gestation who were determined to be at risk for ROP by the attending clinician and were screened for ROP. Exclusion Criteria: * Neonates who died before the first ROP examination are excluded from the study.
Where this trial is running
Ankara
- Baskent University — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Sezin Unal
- Email: sezinunal@gmail.com
- Phone: 0090532
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.